Method of antagonizing the effects of thromboxane
AssigneeSmith Kline Beckman Corporation
InventorsMartin A. Wasserman, Barry M. Weichman
Life of this patent
Estimating the term…
Abstract
Methods of antagonizing the effects of thromboxane A.sub.2 in the circulatory system of an animal which comprises administering to said animal a nontoxic effective amount of N,N'-bis[7-(3-chlorobenzeneaminosulfonyl)-1,2,3,4-tetrahydroisoquinolyl]di sulfonylimide or a pharamaceutical acceptable salt thereof are valuable in the treatment of diseases in which thromboxane A.sub.2 is a factor, such as thrombosis, endotoxic shock and cardiac anaphylaxis.
Claims8
A method of antagonizing the effects of thromboxane A.sub.2 in the circulatory system of an animal which comprises administering to an animal in need of said antagonism a nontoxic effective amount of the active ingredient, N,N'-bis[7-(3-chlorobenzeneaminosulfonyl)-1,2,3,4-tetrahydroisoquinolyl]di sulfonylimide or a pharmaceutically acceptable salt thereof.
A method of inhibiting platelet aggregation which comprises administering to a subject in need of said inhibition a nontoxic effective amount of the active ingredient, N,N'-bis[7(3-chlorobenzeneaminosulfonyl)-1,2,3,4-tetrahydroisoquinolyl]dis ulfonylimide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.